CAPTRUST Financial Advisors
MXCT icon

CAPTRUST Financial Advisors’s MaxCyte MXCT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Buy
31,344
+19,875
+173% +$19.8K ﹤0.01% 3154
2026
Q1 		$8.05K Buy
+11,469
New +$10.7K ﹤0.01% 2999
2023
Q3 		– Sell
-208,448
Closed -$957K – 2683
2023
Q2 		$957K Sell
208,448
-10,808
-5% -$49.7K ﹤0.01% 1233
2023
Q1 		$1.09M Buy
219,256
+38,447
+21% +$189K ﹤0.01% 993
2022
Q4 		$987K Buy
180,809
+80,555
+80% +$494K 0.01% 979
2022
Q3 		$652K Buy
100,254
+100,203
+196,476% +$559K ﹤0.01% 1122
2022
Q2 		$0 Buy
51
+14
+38% +$69 ﹤0.01% 5060
2022
Q1 		$0 Buy
+37
New +$253 ﹤0.01% 5052
2021
Q4 		– Sell
-171
Closed -$2K – 4857
2021
Q3 		$2K Buy
+171
New +$2.58K ﹤0.01% 4281

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

CAPTRUST Financial Advisors's MXCT Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its MaxCyte (MXCT) stake by 173% in Q2 2026, buying an estimated $19.8K and bringing the position to 31,344 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

CAPTRUST Financial Advisors first reported a position in MXCT in Q3 2021 and has held it in 9 quarters since. The position peaked at $1.09M in Q1 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • CAPTRUST Financial Advisors held 31,344 shares of MaxCyte worth $38.6K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 19,875 MaxCyte shares in Q2 2026, an estimated $19.8K.
  • MaxCyte made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3154 holding.
  • CAPTRUST Financial Advisors first reported a position in MaxCyte in Q3 2021 and has held it in 9 quarters since.
  • CAPTRUST Financial Advisors's MaxCyte position peaked at $1.09M in Q1 2023.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.